Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treat Refractory Auditory Hallucinations in Schizophrenia Patients With fMRI-guided Neurofeedback: a Randomized-controlled Trial

NCT04798131 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04798131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treat Refractory Auditory Hallucinations in Schizophrenia Patients With fMRI-guided Neurofeedback: a Randomized-controlled Trial
Lead sponsor
University Hospital, Lille
Phase
Not applicable
Overall status
Recruiting
Start date
August 26, 2022
Completion date
November 30, 2028
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hallucinations, auditory, hallucinations, visual, schizophrenia